Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation  by Fukumoto, Akihisa et al.
FEBS 29238 FEBS Letters 579 (2005) 1047–1054Small Jab1-containing subcomplex is regulated in an anchorage- and
cell cycle-dependent manner, which is abrogated by ras transformation
Akihisa Fukumotoa, Kiichiro Tomodab, Makoto Kubotab, Jun-ya Katob,*, Noriko Yoneda-Katob
a First Department of Surgery, Nara Medical University, Nara, Japan
b Graduate School of Biological Sciences, Nara Institute of Science and Technology, Nara, Japan
Received 12 November 2004; revised 22 December 2004; accepted 28 December 2004
Available online 13 January 2005
Edited by Angel NebredaAbstract Jab1 interacts with a variety of cell cycle and signal
transduction regulators to control cell proliferation, diﬀerentia-
tion, and tumorigenesis. In this study, we employed a non-
denaturing gel electrophoresis method to separate diﬀerent
Jab1-containing complexes, the COP9 signalosome complex
and the small Jab1-containing subcomplex. The formation of the
small Jab1 complex was dependent on a low cell density and
anchorage to a solid support, and enhanced during the early G1
phase of the cell cycle, which was abrogated in ras-transformed
cells. The small Jab1-containing subcomplexmay be a novel medi-
atorof anchorageandcell–cell contact-dependent signal transduction.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Jab1 is a multi-functional protein, which interacts with and
controls multiple intracellular signaling and cell cycle control
molecules such as c-Jun, p27, HIF1a, Smad4, p53, and
CUL1 in mammalian cells [1,2]. High-level expression of
Jab1 is observed in human cancers [3–14] and is sometimes
correlated with a poor prognosis and low level of Cdk inhibi-
tor p27. During development, the level of Jab1 expression is
markedly higher in mouse embryos, where vigorous cell prolif-
eration occurs, than in adult mice [15]. Jab1-null embryos died
soon after implantation and Jab1/ embryonic cells exhib-
ited impaired proliferation and accelerated apoptosis [16].
Most Jab1 protein locates in the nucleus with some in the cyto-
plasm, but strong cytoplasmic Jab1 signals were observed in
terminally diﬀerentiated adult tissues [4,13]. These ﬁndings
suggest that Jab1 plays an important role in the regulation
of mammalian cell proliferation, and the intracellular localiza-
tion as well as expression level of Jab1 is strictly regulated.
Jab1 is also known as the ﬁfth component (CSN5) of the
COP9 signalosome (CSN) complex, which is composed of
eight subunits (CSN1–8) [17], well conserved from yeast to hu-
man, and involved in a variety of biological responses in var-
ious organisms [2,18–21]. CSN associates with diﬀerent types
of enzymes, such as kinases and ligases. CSN-associated*Corresponding author. Fax: +81 743 72 5519.
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phorylation of c-Jun, NFjB, and p53, and inhibition of the
activity results in an accumulation of p53 and eventual cell
cycle arrest/apoptosis [22]. CSN interacts with the SCF
(Skp1-Cullin-F box protein) ubiquitin ligases, and catalyzes
the reaction to remove a ubiquitin-like polypeptide, Nedd8,
from the Cul subunit (deneddylation) [23,24], thereby regulat-
ing the SCF ligase activity [25,26].
Besides being a component of the CSN complex, Jab1 was
also found as a small complex or a monomeric form [27–30].
In murine ﬁbroblasts, the CSN complex locates in the nu-
cleus, whereas the smaller form is predominantly found in
the cytoplasm [30]. Bcr-Abl tyrosine kinase facilitates the
downregulation of p27 by modulating the small Jab1 sub-
complex through the MAP kinase and PI3 kinase signaling
pathways [31]. Jab1+/ MEF cells, in which the amount of
the small Jab1 subcomplex, but not that of CSN, is selec-
tively reduced, exhibit an ineﬃcient downregulation of p27
during G1 and delayed cell cycle progression [16]. These ﬁnd-
ings suggest that the small Jab1 subcomplex plays an impor-
tant role in mammalian cell proliferation, but the precise
mitogenic action of the smaller form remains to be deter-
mined partially because of the heterogeneity of the Jab1-
containing complexes in mammalian cells. In this study, we
employed a non-denaturing gel electrophoresis system (na-
tive-PAGE) to separate the Jab1-containing complexes in
proliferating mammalian cell lysates. Using this method, we
analyzed the dynamics of Jab1-containing complexes in terms
of cell proliferation, cell cycle progression, cell adherence,
and transformation by the ras oncogene.2. Materials and methods
2.1. Cell culture, transfection and cell cycle analysis
Mammalian cell lines used in this study were maintained in Dul-
beccos modiﬁed Eagles medium supplemented with 10% fetal bovine
serum (FBS). For synchronization, cells were exponentially grown in
medium containing 10% FBS until conﬂuent, and replated at a low
density (about 30% conﬂuency). At the appropriate points in time, cells
were harvested and the cell cycle distribution was determined by a ﬂow
cytometric analysis of DNA content as described [30–32]. The ras-
transformed ﬁbroblast cell line was generated by transfecting NIH3T3
mouse ﬁbroblast cells with an expression vector containing GFP-fused
ras cDNA harboring an activating point mutation (glycine to valine at
position 12) and a puromycin-resistance marker gene. Expression of
the GFP-ras fusion protein was conﬁrmed by immunoblotting and
by visualization of the GFP signal under a ﬂuorescent microscope.
GFP-ras-expressing cells grew in the absence of the solid support
and did not stop growing until they reached a very high cell density,blished by Elsevier B.V. All rights reserved.
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ras oncogene and GFP-ras-expressing cells, like other ras-transformed
cells, lost anchorage-dependence and contact inhibition (CI).
2.2. Protein analyses
Cell lysis, gel electrophoresis, immunoblotting, and glycerol gradient
centrifugation were performed using standard procedures [30–32]. For
non-denaturing gel electrophoresis (native-PAGE), cells growing on a
plastic dish were washed twice with PBS, directly lysed in a digitonin-
lysis buﬀer (50 nM Tris, pH 8.0, 120 mM NaCl, 1 mM EDTA, and
0.1% digitonin) containing 0.1 mM PMSF, 0.2 U/ml aprotinin,
10 mM b-glycerophosphate, 0.1 mM Na vanadate, and 1 mM NaF
at 1 · 105 cells/ll (usually 30 ll per 35 mm diameter dish), scraped with
a rubber policeman and transferred into a microfuge tube. Cell lysates
were freeze-thawed and the cell debris was removed by microcentrifu-
gation at full speed. All procedures were performed at 4 C. The sam-
ple was supplemented with 40 nM Tris, pH 6.8 and 10% glycerol and
equal amounts (ca. 100 lg) of total protein were separated on pre-cast
native gradient gels (5–15%; Bio-Craft, Japan) at 4 C without SDS at
5 mA for 16 h followed by 10 mA for 6 h, and analyzed by immuno-
blotting using the antibodies indicated below. In some cases, cells were
suspended in a solution containing trypsin and EDTA, and collected
by low-speed centrifugation before lysis. Where indicated, cell lysates
were incubated at 4 or 37 C in the presence of chemical inhibitors
(MG132 and curcumin) before being loaded onto the gel.
2.3. Antibodies
The generation of antibodies to CSN subunits was described previ-
ously [30]. Mouse monoclonal antibodies to mouse p27 (clone 57) and
c-tubulin (GTU-88) were obtained from Transduction Laboratories
and Sigma, respectively. Rabbit polyclonal antibodies to Cul1
(ZL18) and GFP (Living Colors) were purchased from Zymed and
Clontech, respectively.3. Results and discussion
3.1. Separation of the Jab1-containing complexes by
native-PAGE
Glycerol gradient centrifugation and gel ﬁltration are the
most commonly used methods to separate diﬀerent protein
complexes. However, these methods require special equipment
and a relatively long time to analyze the lysate, which limits the
number of samples that can be analyzed at one time. To solve
these problems, we utilized a non-denaturing gel electrophore-
sis system (native-PAGE) to separate the Jab1-containing
complexes in mammalian cell lysates. Immunoblotting of the
proteins separated by native-PAGE with antibody to Jab1Fig. 1. Separation of Jab1-containing complexes by native-PAGE. (A) The
separated by native-PAGE, transferred to a nitrocellulose membrane, and an
cell lysates isolated from proliferating NIH3T3 and Swiss3T3 mouse ﬁb
subsequently separated by SDS–PAGE (upper panels) and by native-PAGE
antibody to Jab1. The positions of the CSN complex and the small complex a
#18 and #19, predominantly contained the small Jab1-containing complex.identiﬁed two species of Jab1 complexes in murine ﬁbroblasts
(Fig. 1A); a major complex with slow mobility and consisting
of multiple bands, and a faster-migrating minor complex. To
clarify the identity of these forms, the cell lysates ﬁrst fraction-
ated by glycerol gradient centrifugation were separated by na-
tive-PAGE. Fig. 1B shows that the multiple bands with slow
mobility were the large CSN complex and the minor faster-
migrating form corresponded to the small Jab1-containing
subcomplex [30]. Monomeric form of Jab1 was not detected
in any occasion unless the lysate was treated with heat or
strong detergent, which dissociates entire CSN complexes.
Separation of glycerol gradient fractions by SDS–PAGE
(Fig. 2A) and native-PAGE (Fig. 2B) followed by immuno-
blotting with antibodies speciﬁcally recognizing other CSN
subunits (CSN1–8) revealed that the multiple bands with slow
mobility contained all eight CSN components and the intensity
pattern of each band was very similar among diﬀerent anti-
CSN blots, indicating that, although the subunit composition
of the CSN core is the same, living cells contain multiple diﬀer-
ent species of CSN, possibly due to an association with minor
components or post-translational modiﬁcations. Originally,
Seeger et al. [17] showed that the HL60 cell lysate contained
multiple forms of CSN complexes by the non-denaturing elec-
trophoresis method. In addition, CSN-associated kinases were
bound to only ca. 30% of the CSN complex [33], consistent
with our notion that the CSN complex is heterogeneous.
In addition to the large CSN complex, we detected multiple
bands with faster mobility in native-PAGE-separated samples
(Fig. 2B). The intensity and the position of most bands were
not identical among blots obtained with antibodies to diﬀerent
CSN subunits, suggesting that, in addition to Jab1, other CSN
subunits form a variety of smaller complexes. To investigate
whether the small Jab1 complex contains other CSN subunits,
we separated glycerol gradient fractions, #18 and #19, which
exclusively contained small Jab1 complex, by native-PAGE
and analyzed duplicate blots (run side-by-side) using antibod-
ies to Jab1 and other CSN subunits, CSN3, CSN4, CSN7b and
CSN8 (Fig. 2C). The results show that the majority of the
small Jab1 complex (indicated by an arrow) migrated diﬀer-
ently from complexes containing other CSN subunits. We pre-
viously identiﬁed a minor subcomplex (mini-CSN) containing
CSN4, 5, 6, 7, and 8 in murine ﬁbroblasts, but the amount
of each component was not equal, Jab1 being far more abun-cell lysate isolated from proliferating NIH3T3 mouse ﬁbroblasts was
alyzed by immunoblotting using antibody raised against Jab1. (B) The
roblasts were fractionated by glycerol gradient centrifugation and
(lower panels). Jab1 protein was detected by immunoblotting using
re shown. CSN was abundant in fractions #14 and #15, while fractions
Fig. 2. Characterization of the CSN and the sub-CSN complexes by native-PAGE. (A) NIH3T3 cell lysates fractionated by glycerol gradient
centrifugation (fractions #12 to #20) were separated by SDS–PAGE and analyzed by immunoblotting using antibodies speciﬁcally recognizing each
component of CSN. An arrowhead and arrow (in the second panel from the left in the top row) indicate the positions of the full-length CSN2 protein
and the alternatively spliced form of truncated CSN2 (or Alien) polypeptide, respectively. (B) NIH3T3 cell lysates fractionated by glycerol gradient
centrifugation (fractions #12 to #20) were separated by native-PAGE and analyzed by immunoblotting using antibodies speciﬁcally recognizing each
component of CSN [30]. In the anti-CSN2 blot, fractions #16 to #18 predominantly contained the truncated form of CSN2 (Alien) protein, and, in
the anti-CSN1 blot, these minor forms were not evident. The position of the CSN complex is shown by parentheses. (C). The whole lysate (Direct
lysate) and the glycerol gradient fractions, #18 and #19, were separated by native-PAGE and analyzed by immunoblotting using antibodies to Jab1
(left panel), CSN4 (second panel from the left), CSN7b (third panel from the left), CSN8 (fourth panel from the left), and CSN3 (right panel), The
positions of the CSN complex, small Jab1-containing sub-complex (shown by an arrow), and previously described mini-CSN (shown by an
arrowhead) [30] are shown. (D) The cell lysates isolated from various human cell lines and mouse ﬁbroblasts were separated by native-PAGE, and
analyzed by immunoblotting using antibody raised to Jab1. (A–D) Representative blots from several independent experiments are shown.
A. Fukumoto et al. / FEBS Letters 579 (2005) 1047–1054 1049dant than other CSN subunits [30]. This paradox is now clar-
iﬁed. The intracellular abundance of the CSN4, 5, 6, 7, and
8-complex (indicated by an arrowhead in Fig. 2C), was muchless than we anticipated, and Jab1 forms an additional small
subcomplex, presumably by interacting with an unidentiﬁed
partner protein in mammalian cells. Taken together, these
1050 A. Fukumoto et al. / FEBS Letters 579 (2005) 1047–1054results demonstrate that proliferating mammalian cells con-
tained multiple complexes with diﬀerent CSN compositions.
To investigate whether the formation of a Jab1-containing
subcomplex is speciﬁc to mouse ﬁbroblasts, we analyzed vari-
ous human cell lines by native-PAGE. Fig. 2D shows that,
although the levels of expression varied from one cell line to
another, human cell lines that originated from breast cancer
(MCF7 and SKBR3), pancreatic cancer (MIAPaCa2 and
PANC1), cervical carcinoma (HeLa), and embryonic kidney
(293T), as well as mouse ﬁbroblasts (NIH3T3 and Swiss3T3),
contained the small Jab1 complex with a similar mobility.
3.2. In vitro stability of the Jab1-containing complexes
Next, we examined the in vitro stability of the complex in the
cell lysate. Incubation of the lysate from proliferating NIH3T3
cells at 37 C gradually reduced the amount of small Jab1 com-
plex, which was accompanied by a slight increase in CSN (Fig.
3A), and we did not detect monomeric form of Jab1, which mi-
grates faster in a native-PAGE gel. Incubation at 4 C for 2 h
did not alter the amount of small Jab1 complex, suggesting
that this process was energy-dependent. Interestingly, recombi-
nant Jab1 protein exogenously added to the lysate was not eﬃ-
ciently recruited by the large complex (data not shown),
suggesting that Jab1 needs to be in a special form to function
either by association with other proteins or by speciﬁc modiﬁ-
cations. Most chemical inhibitors to various molecules were
not eﬀective in blocking the disappearance of the small Jab1Fig. 3. In vitro stability of CSN and small Jab1 complex. (A) NIH3T3
cell lysates were incubated in vitro at 37 C and at 4 C for the periods
indicated, and analyzed by native-PAGE and anti-Jab1 immunoblot-
ting. (B) The lysates were incubated in the presence of DMSO (carrier),
MG132, and curcumin before native-PAGE and anti-Jab1 immuno-
blotting analysis.complex. Fig. 3B shows a representative example, in which
an inhibitor of proteasomes did not substantially inhibit the
reduction of the small Jab1 complex at 37 C (Only the result
with MG132 is shown. Lactacystin, and LLM were also inef-
fective in this assay. Data not shown.). Other chemical inhibi-
tors such as signal transduction kinase inhibitors (PD98059,
wortmanin, H89, and staurosporin), caspase inhibitors (E-64
and Z-VAD-FMK), and a phosphatase inhibitor (b-glycero-
phophate) were little eﬀective in this assay (data not shown).
However, there was one exception, curcumin. In the presence
of curcumin, the disappearance of the small Jab1 complex
was accelerated. Concomitant with this, the multiple bands
corresponding to the large CSN complex collapsed to form
one single band. The molecular target of curcumin is not fully
uncovered, but it was previously reported that curcumin inhib-
its a protein kinase activity associated with the CSN complex
[34]. It is, therefore, possible that the CSN-associated kinases
play an important role in the organization of the CSN complex
by phosphorylating CSN subunits. Alternatively, curcumin
may control other biochemical reactions (e.g., ubiquitination
or proteolysis) and regulate the Jab1-CSN dynamics.3.3. Anchorage and cell density-dependence of the
Jab1-containing subcomplex
We next examined the eﬀect of anchorage and cell–cell con-
tact on the formation andmaintenance of Jab1-containing com-
plexes. Swiss3T3 mouse ﬁbroblasts were cultured at various cell
densities ranging from 0.5 · 106 cells/cm2 (Asyn, no cell–cell
contact and maximum proliferation) to full contact inhibition
(CI, maximum cell density and little cell proliferation). Cells
were lysed either directly on tissue culture plates (Sc, scrape),
or as a pellet after their suspension and collection in medium
by low-speed centrifugation (P, pellet). The samples were ana-
lyzed by native-PAGE followed by anti-Jab1 immunoblotting
(Fig. 4A). Cells at low density with maximum proliferation
(Asyn) contained a fairly good amount of small Jab1 complex
(Sc), and, interestingly, the complex rapidly disappeared after
ﬂotation by trypsinization (P), whereas the total level of Jab1
was unchanged and no monomeric form was found, suggesting
that the small Jab1 complex was incorporated into CSN. When
cells were made quiescent by CI, the level of the Cdk inhibitor
p27 was markedly high, suggesting that they were not substan-
tially proliferating. In these cells, small Jab1 complex was ex-
pressed at a moderate level (Sc), and, interestingly, no longer
disappeared after trypsinization (P). The reason for the diﬀer-
ence in nature of the small Jab1 complex in proliferating and
quiescent cells is currently unknown.
To examine whether this is due to the side eﬀect of trypsin-
ization, we incubated the trypsinized cells in suspension (Fig.
4B, F, ﬂoating, and NA, non-attached) or attached on a solid
support (A, attached) for 10 and 24 h and analyzed for the for-
mation of the small Jab1 complex. We found that the small
Jab1 complex was eﬃciently formed only when cells were at-
tached to a solid support. Furthermore, we treated cells with
trypsin (Fig. 4C, T) or EDTA (E) alone, which only marginally
released cells from the solid support, and lysed them directly
on a tissue culture plate. We found that either trypsin or
EDTA alone did not substantially reduced the amount of the
small Jab1 complex. These results indicate that downregula-
tion of the small Jab1 complex is not due to the unspeciﬁc
eﬀect of trypsinization but rather due to the loss of anchorage.
Fig. 4. Anchorage, cell density and cell cycle-dependence of the small Jab1 complex formation. (A) Swiss3T3 ﬁbroblasts were plated at a low density
(0.5 · 106 cells/cm2) to obtain maximum proliferation (Asyn) or were grown to full CI. Cells were directly scraped on a tissue culture plate in lysis
buﬀer (Sc), or trypsinized, spun down and lysed as a pellet in lysis buﬀer (P). The cell lysate was separated by native-PAGE (CSN and small complex)
and by SDS–PAGE (total Jab1, p27, and c-tubulin) and analyzed by anti-Jab1 immunoblotting. (B) Trypsinized mouse ﬁbroblasts were plated onto a
tissue culture dish (A, attached), incubated in a test tube (F, ﬂoating), or seeded onto a ultra-low cluster (ULC) plate (Costar) that does not allow cell
attachment (NA, non-attached). After 10 and 24 h, cells were harvested and subjected to the native-PAGE analysis as in (A). (C) Mouse ﬁbroblasts
were treated with PBS (Sc), trypsin alone (T) and EDTA (E) alone, and lysed directly on a tissue culture plate. The cell lysate was subjected to the
native-PAGE analysis as in (A). (D) CI cells were replated in a new dish at a low cell density, incubated for the periods indicated, and directly lysed
on tissue culture plates. Cell lysates were analyzed by native-PAGE (CSN and small complex) and by SDS–PAGE (total Jab1, p27, Cul1, and c-
tubulin) followed by anti-Jab1 immunoblotting. Cell cycle progression was monitored by FACS analysis of the DNA content. (E and F)
Quantiﬁcation of small Jab1 complex (E) and p27 (F) shown in (B). Data were normalized to the expression level of c-tubulin. (G) Cells arrested in
G0/G1 by serum deprivation (0.1% FBS) were stimulated with 10% FBS for the periods indicated, and directly lysed on tissue culture plates. Cell
lysates were analyzed by native-PAGE (CSN and small complex) and by SDS–PAGE (Jab1) followed by anti-Jab1 immunoblotting. FACS analysis
showed that approximately 80% of the cells were in S phase after 18 h of serum stimulation.
A. Fukumoto et al. / FEBS Letters 579 (2005) 1047–1054 10513.4. Oscillation of small Jab1 complex during the cell cycle after
release from contact inhibition
To examine the formation of small Jab1 complex during the
cell cycle, we synchronized Swiss3T3 cells at G0/G1 by CI andallowed them to progress through the G1 phase by re-plating
them on a new dish at low cell density. Cells were harvested
at various times (from 30 min to 18 h) and the samples were
analyzed by native-PAGE and anti-Jab1 immunoblotting
1052 A. Fukumoto et al. / FEBS Letters 579 (2005) 1047–1054(Fig. 4D, E, and F). The amount of small Jab1 complex rap-
idly increased immediately after replating (within 0.5–3 h),
and declined thereafter. The level of small Jab1 complex in
the mid G1-to-S phase was lower than that contained in CI
cells, whereas the mobility pattern in native-PAGE and the
expression level of CSN did not signiﬁcantly change in the cell
cycle. Again, during the cell cycle progression, the total
amount of Jab1 was constant and no monomeric form of
Jab1 was found, suggesting that Jab1 protein shuttled between
CSN and the small Jab1 complex. p27 was abundantly ex-
pressed in CI cells and, after reentry into the cell cycle, the level
of p27 was reduced during G1 in a stepwise fashion. Interest-
ingly, downregulation of p27 coincided with a rapid increase in
small Jab1 complex, implying the involvement of the complex
in the regulation of p27. After the G1/S boundary, p27 was
maintained at a low level. Although the expression of total
Cul1 protein was constant, the neddylated form of Cul1 (the
slower-migrating form) increased from 9 h post-release, consis-
tent with the previous observation that Skp2 was upregulated
after the G1/S boundary [35] and the level of p27 was main-
tained low by SCF in the S phase [36]. Cell cycle experiments
using cells arrested in G0/G1 by serum deprivation and stimu-
lated with 10% FBS also showed that the cells in G1 contained
higher level of the small Jab1 complex (Fig. 4G), demonstrat-
ing that the up- and down-regulation of the small Jab1 com-
plex is not limited to the release from contact inhibition.Fig. 5. ras-mediated transformation abrogated anchorage-dependent
regulation of small Jab1 complex. (A) NIH3T3 ﬁbroblasts expressing
GFP and GFP-ras protein were analyzed by standard immunoblotting
using antibodies recognizing GFP, Jab1, and c-tubulin. (B) A mixed
population of GFP ()- and GFP-Ras (+, ++)-expressing cells were
directly scraped on a tissue culture plate in lysis buﬀer (Sc), or
trypsinized, spun down and lysed as a pellet in lysis buﬀer (P). Cell
lysates were analyzed by native- (CSN and small complex) and SDS–
PAGE (total Jab1) followed by anti-Jab1 immunoblotting.
(C) NIH3T3 ﬁbroblasts expressing GFP and GFP-Ras (+ and ++)
were grown in a tissue culture dish (morphology) and in a 3% soft agar
(colonies in Soft Agar), and photographed under the microscope.
(D) The number of colonies grown in soft agar for 14 days were
enumerated. The averages of three independent experiments are
shown.3.5. ras-mediated transformation abrogated the anchorage-
dependence of small Jab1 complex
It is well known that cells transformed by the ras oncogene
exhibit anchorage-independent growth and lose the negative
growth restraint of CI. We, therefore, examined the eﬀect of
ras transformation on the formation of small Jab1 complex.
Depending on the amount of input plasmid, we isolated two
lines of transformed NIH3T3 cells expressing diﬀerent levels
of ras protein (indicated by + and ++ in Fig. 5). Transforma-
tion by the ras oncogene did not signiﬁcantly alter the level of
total Jab1 expression (Fig. 5A). NIH3T3 cells expressing GFP
and GFP-ras were plated at low cell density and harvested
either by direct scraping or after ﬂotation. The samples were
analyzed by native- and SDS–PAGE followed by immunoblot-
ting (Fig. 5B). The amount of small Jab1 complex in cells at-
tached to the solid support (lanes indicated as Sc) decreased
as cells were transformed by the ras oncoprotein (the ﬁrst,
third and ﬁfth lanes from the left in Fig. 5B). In addition,
the amount of small Jab1 complex in ras-transformed cells
was less reduced after ﬂoatation by trypsinization (P) com-
pared to the control cells (the ﬁrst and second lanes versus
the third and forth lanes from the left. Quantiﬁcation and nor-
malization of the signals revealed that the ratios between Sc
and P are 2.3 for control cells and 1.2 for Ras (+) cells.).
The eﬀect was more prominent in high-ras-expressor cells
(++) (the ﬁfth and sixth lanes from the left. The Sc/P ratio is
1.0.). The observation that transformation with ras markedly
downregulated small Jab1 complex appears paradoxical, but
it is well known that transformation with the ras oncogene re-
sults in a loss of anchorage-dependence and CI on cell prolif-
eration (Fig. 5C and D). Therefore, it is reasonable that
regulation of small Jab1 complex formation is simply lost in
ras-transformed cells. Another possibility is that endogenous
ras activity is required at multiple points during the G1 phase,and one can assume that the constitutively activated ras onco-
gene bypasses the early G1 event, which involves the formation
of small Jab1 complex. Alternatively, the turnover of Jab1 be-
tween CSN and the small subcomplex may be highly acceler-
ated in ras-transformed cells, resulting in a decrease in the
statistic pool of small Jab1 complex. Whichever the case, these
results indicate that transformation by ras abrogated the regu-
lation of small Jab1 complex, as well as anchorage-dependence
and CI.4. Conclusion
In this study, we optimized conditions for non-denaturing
polyacrylamide electrophoresis (native-PAGE) and success-
A. Fukumoto et al. / FEBS Letters 579 (2005) 1047–1054 1053fully separated the CSN subunit-containing complexes in
mammalian cells. Unexpectedly, we identiﬁed a novel Jab1
subcomplex as well as multiple species of the CSN complex,
which were presumably generated by post-translational modi-
ﬁcations or by association with unknown subunits. The phys-
iological signiﬁcance of the smaller form remains to be
determined. However, because disruption of one CSN subunit
does not necessarily result in the same phenotype as nulliﬁca-
tion of the others [37], it has been suggested that each CSN
subunit has its own unique function/activity [38] in addition
to being a component of the CSN complex, and it is tempting
to hypothesize that the smaller form participates in this sub-
unit-speciﬁc function. Since p27 upregulation is observed in
Jab1 knockout cells [16], but not in CSN2/ and CSN3/
 cells, and only the Jab1 protein is found to be overexpressed
in cancer cells [3–14], identiﬁcation of the Jab1-speciﬁc partner
protein would be critical to understanding the molecular mech-
anism of mammalian cell proliferation, diﬀerentiation and
malignant transformation.
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